Skip to content

CRDF - Cardiff Oncology, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Cardiff Oncology Inc

CRDF · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CRDFCardiff Oncology Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.31
52-wk low: $0.76
Prev close: $1.89
Mkt cap: $69.9M
Beta: 1.44
P/S: 137.5x

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$3.0M

AQ
AQR
Q2 2026 13F
$450K
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Reported Aug 4, 2026

Earnings came in 17.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $70M

Valuation

P/S137.50
P/B2.60

Quality

Operating margin-9245.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CRDF
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $69.85M
Beta: 1.44

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.6x

Profit margin

+0.0%

Op margin

-9245.0%

ROE

-94.1%

$211K

position

CI

Citadel

Ken Griffin · Q1 2026 13F

$203K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CRDF

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.14+17.6%

-$0.17 expected

Next report

What the street expects next

-94.1%

ROA-46.7%

Growth

Beta1.44